ArticlebioRxiv : the preprint server for biology2025
A Systematic Benchmark of High-Accuracy PacBio Long-Read RNA Sequencing for Transcript-Level Quantification.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
7 authors.
Funding
Abstract
PacBio long-read RNA sequencing resolves transcripts with greater clarity than short-read technologies, yet its quantitative performance remains under-evaluated at scale. Here, we benchmark the high-throughput PacBio Kinnex platform against Illumina short-read RNA-seq using matched, deeply sequenced datasets across a time course of endothelial cell differentiation. Compared to Illumina, Kinnex achieved comparable gene-level quantification and more accurate transcript discovery and transcript quantification. While Illumina detected more transcripts overall, many reflected potentially unstable or ambiguous estimates in complex genes. Kinnex largely avoids these issues, producing more reliable differential transcript expression (DTE) calls, despite a mild bias against short transcripts (<1.25 kb). When correcting Illumina for inferential variability, Kinnex and Illumina quantifications were highly concordant, demonstrating equivalent performance. We also benchmarked long-read tools, nominating Oarfish as the most efficient for our Kinnex data. Together, our results establish Kinnex as a reliable platform for full-length transcript quantification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.